Advertise on podcast: SPEED OF LIFE – Building a strong and sustainable Life science sector – together

We meet Håkan Engqvist - the Inventor. Håkan shares his view on making research ideas into commercial success.

We meet Christel Bergström - the Research leader. Christel shares how she balances her work and how she blows off some steam, as the researcher-entrepreneur-professor-program director she is.

We meet Johan Sundström - the Curious Researcher. Johan shares his thoughts on interdisciplinary work, free will, and paradigm shifts.

We meet Ulf Landegren - one of Uppsala Prominent figures. Ulf shares his story from his early days to his view on commercializing research.

We meet Sara Mangsbo - the Super Entrepreneur. Sara shares her motivations and rationale behind the decisions she has made in her career - in a very thoughtful way. 

When animal owners thought it was complicated and slow to send in samples for parasitological analysis, Vidilab solved the problem by developing kollamasken, one of the earliest sample kits on the market, aimed directly for the consumer. kollamasken is a sampling kit containing everything the animal owner needs to easily collect, package and send the sample to the laboratory. On the outside of the box the laboratory address and pre-paid postage is printed, making it even easier for the consumer.

Monitoring made AccessibleThe Cavidi BOLD add-on technology makes highly reliable, incredibly sensitive biomarker detection accessible to all researchers and clinicians globally. The technology requires no specialized equipment or expensive investments. In the lab this will help researchers and drug development teams get to market sooner with life-saving innovations.The Cavidi goal is to democratise ultrasensitive detection.

Rarity BioScience has developed an ultrasensitive and multiplex technology for mutation detection in liquid biopsies, meaning that we can detect down to 1 mutation in 100,000 healthy cells, which is up to 100 times more sensitive than current technology. And perhaps the best part, the assays are run using existing instruments already available in every hematology lab.We provide the sensitive and cost efficient tools needed to replace conventional costly and painful tissue biopsies with blood samples to enable early detection of cancer relapse and treatment response.Rarity is funded by seasoned Uppsala entrepreneurs and researchers, combining previously successful technologies in an ingenious and beautiful way.

Digitalization has been a hot topic that has been accelerated by the recent pandemic, making us rethink the way we work. The knock-on effects have led to digital business transformations in the life sciences such as digital health apps that enable a more holistic healthcare and digital research & development for accelerated research. Listen more to hear why this trend is important to STUNS!

Ridgeview Instruments provides LigandTracer® instruments, TraceDrawer® evaluation software and Education to generate insights on biological interactions with live cells. Our products are typically used to improve the design of protein-based therapeutics and target specific PET/SPECT tracers. Ridgeview Instruments is built from the ground up without public investor, has a strong research focus and sustainable growth for over 15 years and has instruments in over 25 countries worldwide. In this podcast, Jos Buijs, CEO, and Sina Bondza, Principal scientist, talk about company culture, business strategy and the way they work in a collaborative manner with both industry and academia.

Previct is a digital platform for efficient and successful addiction treatment. The therapist receives reports about the patient’s wellbeing and sobriety in real-time, predicting relapses before they occur.Previct also enables faster and more frequent interactions with the patient, and makes it possible for the patient’s family to assist in the treatment. The healthcare provider gain invaluable knowledge while the patient receives daily behavioral therapy, a path leading to deeper and more constructive treatment sessions.

Life science is a sector that has a close relationship with health, well-being and life itself. Naturally much focus within the business community is on the SDG goal number 3, which manifests the very core of the sector itself. Moreover, there is a common understanding through out the sector today that a green transition and a sustainable development is of necessity, if there is to be a healthy and sustainable future.However, to contribute to the sustainable can be manifested in different ways but action is key. Other success factors is communication, collaboration, quantity, involve everyone and own the goals. To form sustainable collaborations STUNS has an important role.Listen to Fanny Blom, who is responsible for the area sustainability in life science at STUNS Life science, sharing her analysis of sustainability within the local life science sector and why we at STUNS engage in this area.